{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:15:08Z","timestamp":1763057708997},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,7,8]],"date-time":"2012-07-08T00:00:00Z","timestamp":1341705600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00430-012-0254-1","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T20:18:13Z","timestamp":1348085893000},"page":"175-182","source":"Crossref","is-referenced-by-count":8,"title":["Single oral administration of the novel CXCR4 antagonist, KRH-3955, induces an efficient and long-lasting increase of white blood cell count in normal macaques, and prevents CD4 depletion in SHIV-infected macaques: a preliminary study"],"prefix":"10.1007","volume":"202","author":[{"given":"Tadashi","family":"Nakasone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei","family":"Kumakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,8]]},"reference":[{"key":"254_CR1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2141.2010.08361.x","volume":"151","author":"G Bouma","year":"2010","unstructured":"Bouma G, Ancliff PJ, Thrasher AJ, Burns SO (2010) Recent advances in the understanding of genetic defects of neutrophil number and function. Br J Haematol 151:312\u2013326","journal-title":"Br J Haematol"},{"key":"254_CR2","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1073\/pnas.0901162106","volume":"106","author":"AA Navarini","year":"2009","unstructured":"Navarini AA, Lang KS, Verschoor A et al (2009) Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections. Proc Natl Acad Sci USA 106:7107\u20137112","journal-title":"Proc Natl Acad Sci USA"},{"key":"254_CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1634\/stemcells.2007-0416","volume":"26","author":"L Raffaghello","year":"2008","unstructured":"Raffaghello L, Bianchi G, Bertolotto M et al (2008) Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 26:151\u2013162","journal-title":"Stem Cells"},{"key":"254_CR4","first-page":"753","volume-title":"Production, distribution and fate of neutrophils","author":"B Babior","year":"2001","unstructured":"Babior B (2001) Production, distribution and fate of neutrophils. McGraw-Hill, New York, pp 753\u2013759"},{"key":"254_CR5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1600-065X.2007.00550.x","volume":"219","author":"WM Nauseef","year":"2007","unstructured":"Nauseef WM (2007) How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 219:88\u2013102","journal-title":"Immunol Rev"},{"key":"254_CR6","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1128\/IAI.61.12.5090-5096.1993","volume":"61","author":"HW Rogers","year":"1993","unstructured":"Rogers HW, Unanue ER (1993) Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun 61:5090\u20135096","journal-title":"Infect Immun"},{"key":"254_CR7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jlb.57.6.827","volume":"57","author":"AL Rakhmilevich","year":"1995","unstructured":"Rakhmilevich AL (1995) Neutrophils are essential for resolution of primary and secondary infection with Listeria monocytogenes. J Leukoc Biol 57:827\u2013831","journal-title":"J Leukoc Biol"},{"key":"254_CR8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jlb.65.2.196","volume":"65","author":"H Lundqvist-Gustafsson","year":"1999","unstructured":"Lundqvist-Gustafsson H, Bengtsson T (1999) Activation of the granule pool of the NADPH oxidase accelerates apoptosis in human neutrophils. J Leukoc Biol 65:196\u2013204","journal-title":"J Leukoc Biol"},{"key":"254_CR9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1517\/13543784.2012.656197","volume":"21","author":"A Peled","year":"2012","unstructured":"Peled A, Wald O, Burger J (2012) Development of novel CXCR4-based therapeutics. Expert Opin Investig Drugs 21:341\u2013353","journal-title":"Expert Opin Investig Drugs"},{"key":"254_CR10","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.44.6.1667-1673.2000","volume":"44","author":"CW Hendrix","year":"2000","unstructured":"Hendrix CW, Flexner C, MacFarland RT et al (2000) Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother 44:1667\u20131673","journal-title":"Antimicrob Agents Chemother"},{"key":"254_CR11","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1073\/pnas.0630420100","volume":"100","author":"K Ichiyama","year":"2003","unstructured":"Ichiyama K, Yokoyama-Kumakura S et al (2003) A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity. Proc Natl Acad Sci USA 100:4185\u20134190","journal-title":"Proc Natl Acad Sci USA"},{"key":"254_CR12","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/AAC.01727-08","volume":"53","author":"T Murakami","year":"2009","unstructured":"Murakami T, Kumakura S, Yamazaki T et al (2009) The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100. Antimicrob Agents Chemother 53:2940\u20132948","journal-title":"Antimicrob Agents Chemother"},{"key":"254_CR13","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2217\/fmb.10.67","volume":"5","author":"T Murakami","year":"2010","unstructured":"Murakami T, Yamamoto N (2010) Role of CXCR4 in HIV infection and its potential as a therapeutic target. Future Microbiol 5:1025\u20131039","journal-title":"Future Microbiol"},{"key":"254_CR14","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1099\/0022-1317-80-5-1231","volume":"80","author":"K Shinohara","year":"1999","unstructured":"Shinohara K, Sakai K, Ando S et al (1999) A highly pathogenic simian\/human immunodeficiency virus with genetic changes in cynomolgus monkey. J Gen Virol 80:1231\u20131240","journal-title":"J Gen Virol"},{"key":"254_CR15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0042-6822(03)00434-3","volume":"313","author":"M Kaizu","year":"2003","unstructured":"Kaizu M, Ami Y, Nakasone T et al (2003) Higher levels of IL-18 circulate during primary infection of monkeys with a pathogenic SHIV than with a nonpathogenic SHIV. Virology 313:8\u201312","journal-title":"Virology"},{"key":"254_CR16","first-page":"277","volume":"31","author":"T Nakasone","year":"2002","unstructured":"Nakasone T, Sakai K, Ami Y et al (2002) Genetic and biological characterization of a highly pathogenic molecular clone, SHIV-C2\/1 KS661. J Med Primatol 31:277","journal-title":"J Med Primatol"},{"key":"254_CR17","first-page":"308","volume":"36","author":"T Nakasone","year":"2007","unstructured":"Nakasone T, Kanekiyo M, Yoshino N et al (2007) Cell-associated SHIV infection in cynomolgus monkeys. J Med Primatol 36:308\u2013309","journal-title":"J Med Primatol"},{"key":"254_CR18","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1128\/JVI.79.20.12871-12879.2005","volume":"79","author":"Y Ami","year":"2005","unstructured":"Ami Y, Izumi Y, Matsuo K et al (2005) Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Gu\u00e9rin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity. J Virol 79:12871\u201312879","journal-title":"J Virol"},{"key":"254_CR19","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/QAD.0b013e32832e5331","volume":"23","author":"T Murakami","year":"2009","unstructured":"Murakami T, Eda Y, Nakasone T et al (2009) Postinfection passive transfer of KD-247 protects against simian\/human immunodeficiency virus-induced CD4+\u00a0T-cell loss in macaque lymphoid tissue. AIDS 23:1485\u20131494","journal-title":"AIDS"},{"key":"254_CR20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.virol.2007.06.012","volume":"367","author":"K Someya","year":"2007","unstructured":"Someya K, Xin KQ, Ami Y et al (2007) Chimeric adenovirus type 5\/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian\/human immunodeficiency virus in monkeys. Virology 367:390\u2013397","journal-title":"Virology"},{"key":"254_CR21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.micinf.2006.01.011","volume":"8","author":"M Motohara","year":"2006","unstructured":"Motohara M, Ibuki K, Miyake A et al (2006) Impaired T-cell differentiation in the thymus at the early stages of acute pathogenic chimeric simian-human immunodeficiency virus (SHIV) infection in contrast to less pathogenic SHIV infection. Microbes Infect 8:1539\u20131549","journal-title":"Microbes Infect"},{"key":"254_CR22","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1099\/vir.0.81307-0","volume":"87","author":"A Miyake","year":"2006","unstructured":"Miyake A, Ibuki K, Enose Y et al (2006) Rapid dissemination of a pathogenic simian\/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection. J Gen Virol 87:1311\u20131320","journal-title":"J Gen Virol"},{"key":"254_CR23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virol.2010.01.008","volume":"399","author":"K Matsuda","year":"2010","unstructured":"Matsuda K, Inaba K, Fukazawa Y et al (2010) In vivo analysis of a new R5 tropic SHIV generated from the highly pathogenic SHIV-KS661, a derivative of SHIV-89.6. Virology 399:134\u2013143","journal-title":"Virology"},{"key":"254_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00042560-199606010-00001","volume":"12","author":"Y Lu","year":"1996","unstructured":"Lu Y, Salvato MS, Pauza CD et al (1996) Utility of SHIV for testing HIV-1 vaccine candidates in macaques. J Acquir Immune Defic Syndr Hum Retrovirol 12:99\u2013106","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"254_CR25","doi-asserted-by":"crossref","unstructured":"Nakasone T, Murakami T, Yamamoto N (2012) Double oral administration of emtricitabine\/tenofovir prior to virus exposure protects against highly pathogenic SHIV infection in macaques. Jpn J Infect Dis 65(4)","DOI":"10.7883\/yoken.65.345"},{"key":"254_CR26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pharmthera.2010.08.009","volume":"128","author":"E Clercq De","year":"2010","unstructured":"De Clercq E (2010) Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil\u2122) and potential of other CXCR4 antagonists as stem cell mobilizers. Pharmacol Ther 128:509\u2013518","journal-title":"Pharmacol Ther"},{"key":"254_CR27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.chom.2010.11.006","volume":"8","author":"KY Chow","year":"2010","unstructured":"Chow KY, Brotin \u00c9, Ben Khalifa Y et al (2010) A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome. Cell Host Microbe 8:523\u2013533","journal-title":"Cell Host Microbe"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-012-0254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-012-0254-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-012-0254-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:46:04Z","timestamp":1594687564000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-012-0254-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,8]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1007\/s00430-012-0254-1","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,8]]}}}